USCTF:US
$4.32
0.232%

Verve Therapeutics Inc.
Key Data

Last updated: May 15, 2025, 11:11 PM ET

Price Metrics  

  • Open
    4.25
  • Close
    4.32
  • Prev. Close
    4.31
  • Day High/Low
    4.325/3.95
  • 52 Week High/Low
    9.305/2.865
  • Alpha
    -0.029
  • Beta
    1.827
  • VWAP
    4.151

Moving Averages  

  • 21 Day Moving Average
    4.918
  • 50 Day Moving Average
    4.981
  • 200 Day Moving Average
    5.734

Valuation Metrics  

  • Market Cap (All Classes)
    383,597,718.00
  • Market Cap
    383,597,718.00
  • EPS (TTM)
    —
  • P/E Ratio (TTM)
    —
  • P/B Ratio
    0.78
  • P/CF Ratio
    -2.30
  • D/E Ratio
    0.14
  • Return on Equity
    -36.36%
  • Return on Assets
    -28.39%

Share Statistics  

  • Total Shares (All Classes)
    88,795,768.00
  • Listed Shares Outstanding
    88,795,768.00
  • Escrow Shares
    —
  • Volume
    2,509,295.00
  • 10 Day Avg Vol.
    3,080,318.00
  • 20 Day Avg Vol.
    3,051,280.00
  • 30 Day Avg Vol.
    4,775,138.00
  • 50 Day Avg Vol.
    3,382,184.00

Dividends  

  • Dividend
    —
  • Dividend Frequency
    —
  • Dividend Yield (Ann)
    —
  • Ex-Date
    —
  • Payable date
    —
  • Dividend Growth (3 Year)
    —
  • Dividend Growth (5 Year)
    —

Short Interest (as of May 16, 2025)  

  • Short Interest as % of Float
    -%
  • Short Interest Days to Cover
    -
Want more in-depth company research in real-time?
Learn more about TMX Powerstream today.